Latest News

Medtronic collaborating with the NHS to create Project WOW 

Discover how Covid-19 resulted in the creation of Project WOW, to assist the NHS deal with large number of endoscopy backlog.

See Also

The Revolution and Evolution of Pillcam™ Capsule Endoscopy

Listen to Dr. Crisitano Spada recall how PillCam™ capsule endoscopy changed the course of gastroenterology and became a standard of care around the globe.**


More detail. More efficiency. More confidence to treat your patients.*1,2,3

The PillCam™ SB 3 system allows for direct visualization of the small bowel, supporting greater confidence when monitoring lesions3 that may be related to GI bleeding, iron deficiency anemia, or Crohn's disease. The system features advanced optics and imaging designed to deliver exceptional images of the mucosa.

This system includes innovative features like adaptive frame rate technology, which supports image acquisition that is uniquely suited to each patient's motility, as well as the tools you need to record and interpret study results. The software contains our most advanced algorithms, providing you with the tools you need to efficiently read and interpret study results.

Download the latest PillCam Software Reader

Download Now

PillCam™ SB 3 Animation Video

Safety Comes First

The PillCam™ patency capsule is a dissolvable capsule that provides a simple and convenient way to verify adequate patency of the gastrointestinal tract prior to PillCam™ capsule endoscopy. In patients with known or suspected strictures, a PillCam™ patency capsule may be given to help physicians assess if capsule endoscopy is a good option.

Visualize with Confidence

Product Features

High accuracy:

  • Excellent image quality
  • Improved efficiency
  • Exclusive software features

Complete and detailed visualization of the small bowel through:

  • Adaptive Frame Rate (AFR): 2-6 images per second based on the capsule movement
  • Wide angle view
  • Increased battery capacity


Indications for Use

The PillCam™ Platform with a PillCam™ SB capsule is intended for visualization of the small bowel mucosa.

  • PillCam™ Platform with PillCam™ SB capsule may be used in the visualization and monitoring of lesions that may indicate Crohn’s disease not detected by upper and lower endoscopy.
  • PillCam™ Platform with PillCam™ SB capsule may be used in the visualization and monitoring of lesions that may be a source of obscure bleeding (either overt or occult) not detected by upper and lower endoscopy.
  • PillCam™ Platform with PillCam™ SB capsule may be used in the visualization and monitoring of lesions that may be potential causes of iron deficiency anemia (IDA) not detected by upper and lower endoscopy.

The Suspected Blood Indicator (SBI) feature is intended to mark frames of the video suspected of containing blood or red areas.

The PillCam™ Platform with PillCam™ SB capsules may be used as a tool in the detection of abnormalities of the small bowel and is intended for use in adults and children from two years of age.


The PillCam™ SB capsules are contraindicated for use under the following conditions:

  • In patients with known or suspected gastrointestinal obstruction, strictures, or fistulas based on the clinical picture or pre-procedure testing and profile.
  • In patients with cardiac pacemakers or other implanted electromedical devices.
  • In patients with swallowing disorders.

Note: The SB PillCam™ Capsule may be deployed by using transendoscopic delivery in patients who are either unable to ingest the PillCam™ capsule or are known to have slow gastric emptying time. Placement into the duodenum is recommended to prevent the patient from vomiting the capsule.

Procedure Risk Information

The risks of PillCam™ SB 3 capsule include capsule retention, aspiration, and skin irritation.

Endoscopic placement may present additional risks.Medical, endoscopic, or surgical intervention may be necessary to address any of these complications, should they occur.

After ingesting the PillCam™ SB 3 capsule, and until it is excreted, patients should not be near any source of powerful electromagnetic fields, such as one created near an MRI device.

Please refer to the product user manual for detailed information.

Order Information
Order Code Description Unit of Measure Quantity
FGS-0391 PillCam™ SB 3 Capsule Pack 1
FGS-0395 PillCam™ SB 3 Capsule Pack 5
FGS-0400 PillCam™ SB 3 Capsule Pack 10


Adaptive frame rate technology

The PillCam™ SB 3 system optimizes tissue coverage with the most advanced capsule endoscopy technology.

  • Capture image rate changes from 2 to 6 fps when the system determines the capsule is moving more quickly.
  • Increased frame rate flexibility maximizes mucosa coverage and supports tissue acquisition that is uniquely suited to each patient’s motility.
  • High-quality imaging supports greater diagnostic confidence—In one survey, 100% of GIs ranked the image sharpness, natural tissue colors, balanced illumination, and overall image quality provided by the PillCam™ SB 3 system higher than that of the previous generation.3
  • Proprietary software algorithms enable smarter video compilation that is 40% more efficient than the PillCam™ SB 2 system.2

Small capsule. Big impact.

For 20 years, PillCam™ capsule endoscopy has been creating new futures for patients looking for answers. Learn about PillCam's global impact, and its continuous innovation. 

How PillCamTM can help during COVID-19

Alleviate burden. Support efficient patient management.

We know that determining whether to perform an urgent procedure is a complex decision under today’s circumstances. PillCam™ capsule endoscopy can help your decision-making process and offer several benefits.

Interested in learning more?

Contact us to learn more about the clinical and patient benefits of the PillCamTM Capsule Endoscopy System.

PillCam Capsule Endoscopy System.
  • * Compared to PillCam™ SB 2 system.

  • † Allows video reviewing and reporting, but not video creation.

  • ** Cotter J, Castro F, Magalhaes J, Moreira M, Rosa B. Validation of the Lewis score for the evaluation of small-bowel Crohn’s disease activity. Endoscopy. 2015 Apr;47(4):330-5.